CAS 1192171-69-9

Formula: C19H15Cl3N2O5S

InChI: InChI=1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26)

InChI key: XLGQSYUNOIJBNR-UHFFFAOYSA-N

SMILES: C1CN(CCN1C2=C(C3=C(C=C2)OC(=C3)C(=O)O)Cl)S(=O)(=O)C4=C(C=CC=C4Cl)Cl

4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid

CAS: 1192171-69-9

4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: 98%

Peso molecolare: 489.76

Ref: 54-OR1023053

Vonafexor

CAS: 1192171-69-9

Vonafexor

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: ≥98%

Peso molecolare: 489.76

Ref: 54-BUP06737

4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid

CAS: 1192171-69-9

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: 98%

Colore e forma: Solid

Peso molecolare: 489.7568

Ref: IN-DA01V2UY

Vonafexor

CAS: 1192171-69-9

Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: 98.74%

Colore e forma: White Solid

Peso molecolare: 489.757

Ref: TM-T8471

Vonafexor

CAS: 1192171-69-9

4-Chloro-5-(4-((2,6-dichlorophenyl)sulfonyl)piperazin-1-yl)benzofuran-2-carboxylic acid

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: 98%

Peso molecolare: 489.76

Ref: IN-DG01218047

Vonafexor

CAS: 1192171-69-9

Vonafexor is an inhibitor that is used in combination with other drugs for the treatment of non-alcoholic steatohepatitis. Vonafexor is a potent inhibitor of fatty acid synthase, which may be responsible for the reduction of liver fat and inflammation in patients with non-alcoholic steatohepatitis. It has also been shown to inhibit lipoprotein lipase and block sterol uptake, leading to decreased cholesterol synthesis. Vonafexor has not been associated with any adverse events and has no known drug interactions.

Formula: C₁₉H₁₅Cl₃N₂O₅S

Purezza: Min. 95%

Peso molecolare: 489.8 g/mol

Ref: 3D-SXB17169